MKI67 and neoplasm: By using Ki-67 staining, we proved that the knockdown of circKRT17 alone significantly repressed tumor cell proliferation, and the combination of osimertinib and shcircKRT17 further repressed tumor cell proliferation (Figure 8D,E).